Fund profile · Compiled from public sources

Global BioAccess Fund

New York, USA · Pre-seed → Seed

Their stated focus (public profile)

Global BioAccess Fund invests in early-stage companies developing novel therapeutics and devices to address serious unmet medical needs across oncology, immunology & inflammation, rare diseases, CNS, and cardiology. The fund focuses on transformative technologies and partners with forward-thinking companies to advance novel science into new medicines. It provides capital to support IND submissions and clinical trials.

Stages: Pre-seed → Seed

Sectors: Life sciences, Cns, Cardiology, Medtech

On file: 7 partners on record · 9 companies on record

Website: globalbioaccess.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →